BSE Live
Jan 27, 16:01Prev. Close
207.35
Open Price
205.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 27, 15:55Prev. Close
207.16
Open Price
210.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
203.85 (1044)
| Key Financial Ratios of Viyash Scientific (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 9.79 | 3.17 | 1.83 | 10.23 | 5.77 | |
| Diluted EPS (Rs.) | 9.79 | 3.17 | 1.83 | 10.23 | 5.77 | |
| Cash EPS (Rs.) | 15.69 | 6.91 | 4.03 | 11.67 | 6.60 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 54.56 | 53.76 | 48.39 | 41.73 | 30.47 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 54.56 | 53.76 | 48.39 | 41.73 | 30.47 | |
| Dividend / Share(Rs.) | 2.00 | 1.00 | 1.00 | 1.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 116.00 | 95.74 | 60.80 | 49.20 | 46.47 | |
| PBDIT/Share (Rs.) | 27.73 | 11.73 | 6.01 | 13.76 | 9.17 | |
| PBIT/Share (Rs.) | 21.83 | 7.99 | 3.81 | 12.32 | 8.34 | |
| PBT/Share (Rs.) | 14.30 | 4.99 | 2.47 | 11.94 | 8.29 | |
| Net Profit/Share (Rs.) | 9.79 | 3.17 | 1.83 | 10.23 | 5.77 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 23.90 | 12.24 | 9.88 | 27.97 | 19.72 | |
| PBIT Margin (%) | 18.82 | 8.34 | 6.26 | 25.03 | 17.95 | |
| PBT Margin (%) | 12.32 | 5.21 | 4.06 | 24.27 | 17.84 | |
| Net Profit Margin (%) | 8.44 | 3.31 | 3.01 | 20.78 | 12.42 | |
| Return on Networth / Equity (%) | 17.94 | 5.90 | 3.79 | 24.50 | 18.94 | |
| Return on Capital Employed (%) | 10.02 | 3.99 | 2.81 | 23.17 | 17.81 | |
| Return on Assets (%) | 6.00 | 2.70 | 1.98 | 16.67 | 13.66 | |
| Total Debt/Equity (X) | 1.18 | 0.83 | 0.47 | 0.14 | 0.00 | |
| Asset Turnover Ratio (%) | 71.10 | 81.65 | 65.68 | 80.22 | 109.98 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.12 | 1.81 | 1.71 | 1.79 | 2.25 | |
| Quick Ratio (X) | 0.79 | 1.29 | 1.21 | 1.44 | 1.96 | |
| Inventory Turnover Ratio (X) | 5.28 | 4.85 | 4.39 | 8.02 | 16.08 | |
| Dividend Payout Ratio (NP) (%) | 20.42 | 31.51 | 68.22 | 9.77 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 12.74 | 14.46 | 31.04 | 8.56 | 0.00 | |
| Earnings Retention Ratio (%) | 79.58 | 68.49 | 31.78 | 90.23 | 100.00 | |
| Cash Earnings Retention Ratio (%) | 87.26 | 85.54 | 68.96 | 91.44 | 100.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 413.68 | 95.25 | 80.33 | 43.41 | 23.91 | |
| EV/Net Operating Revenue (X) | 1.68 | 0.90 | 1.19 | 1.18 | 0.79 | |
| EV/EBITDA (X) | 7.03 | 7.33 | 12.06 | 4.21 | 4.01 | |
| MarketCap/Net Operating Revenue (X) | 1.17 | 0.47 | 0.88 | 1.22 | 0.86 | |
| Retention Ratios (%) | 79.57 | 68.48 | 31.77 | 90.22 | 100.00 | |
| Price/BV (X) | 2.50 | 0.84 | 1.10 | 1.44 | 1.31 | |
| Price/Net Operating Revenue | 1.17 | 0.47 | 0.88 | 1.22 | 0.86 | |
| Earnings Yield | 0.07 | 0.07 | 0.03 | 0.17 | 0.14 |
02.12.2025
Sequent Scienti Standalone September 2025 Net Sales at Rs 34.03 crore, down 18.96% Y-o-Y
22.08.2025
Sequent Scienti Standalone June 2025 Net Sales at Rs 41.07 crore, down 28.78% Y-o-Y
21.05.2025
Sequent Scienti Standalone March 2025 Net Sales at Rs 42.33 crore, up 15.12% Y-o-Y
24.02.2025
Sequent Scienti Consolidated December 2024 Net Sales at Rs 390.81 crore, up 18.66% Y-o-Y